Global Multiple Myeloma Drugs Market 2023-2027

PUBLISHED: October 31, 2022

PAGES: 120 Pages

DELIVERY TIME: 1-2 business days

ADD TO COMPARE

SELECT AN OPTION

Technavio has been monitoring the multiple myeloma drugs market and is poised to grow by $6419.94 mn from 2023-2027, accelerating at a CAGR of 5.9% during the forecast period. Our report on the multiple myeloma drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the growing incidence of multiple myeloma, growing demand for biological therapies, and a strong adoption rate.

Technavio's multiple myeloma drugs market is segmented as below:

By Therapy Outlook

Targeted therapy
Biologic therapy
Chemotherapy
Others

By Distribution Channel

Hospital pharmacy
Retail pharmacy
E-pharmacy

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the emergence of the nanomedicine platform as one of the prime reasons driving the multiple myeloma drugs market growth during the next few years. Also, the advent of micro therapeutics and rapid growth potential in developing economies will lead to sizable demand in the market.

Multiple myeloma drugs market sizing
Multiple myeloma drugs market forecast
Multiple myeloma drugs market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading multiple myeloma drugs market vendors that include Abbott Laboratories, AbbVie Inc., Amgen Inc., AstraZeneca Plc, Bristol Myers Squibb Co., Cipla Ltd., Daiichi Sankyo Co. Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Fresenius SE and Co. KGaA, GlaxoSmithKline Plc, Johnson and Johnson, Merck and Co. Inc., Novartis AG, Pfizer Inc., PharmaMar SA, Sanofi SA, Takeda Pharmaceutical Co. Ltd., and Teva Pharmaceutical Industries Ltd. Also, the multiple myeloma drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Product Code: IRTNTR74700

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Therapy
Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

4.1 Global multiple myeloma drugs market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on Global multiple myeloma drugs market 2017 - 2021 ($ million)
4.2 Therapy Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Therapy Segment 2017 - 2021 ($ million)
4.3 Distribution Channel Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Therapy

6.1 Market segments
Exhibit 30: Chart on Therapy - Market share 2022-2027 (%)
Exhibit 31: Data Table on Therapy - Market share 2022-2027 (%)
6.2 Comparison by Therapy
Exhibit 32: Chart on Comparison by Therapy
Exhibit 33: Data Table on Comparison by Therapy
6.3 Targeted therapy - Market size and forecast 2022-2027
Exhibit 34: Chart on Targeted therapy - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Targeted therapy - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Targeted therapy - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Targeted therapy - Year-over-year growth 2022-2027 (%)
6.4 Biologic therapy - Market size and forecast 2022-2027
Exhibit 38: Chart on Biologic therapy - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Biologic therapy - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Biologic therapy - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Biologic therapy - Year-over-year growth 2022-2027 (%)
6.5 Chemotherapy - Market size and forecast 2022-2027
Exhibit 42: Chart on Chemotherapy - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Data Table on Chemotherapy - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Chart on Chemotherapy - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Chemotherapy - Year-over-year growth 2022-2027 (%)
6.6 Others - Market size and forecast 2022-2027
Exhibit 46: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 47: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 48: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 49: Data Table on Others - Year-over-year growth 2022-2027 (%)
6.7 Market opportunity by Therapy
Exhibit 50: Market opportunity by Therapy ($ million)

7 Market Segmentation by Distribution Channel

7.1 Market segments
Exhibit 51: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibit 52: Data Table on Distribution Channel - Market share 2022-2027 (%)
7.2 Comparison by Distribution Channel
Exhibit 53: Chart on Comparison by Distribution Channel
Exhibit 54: Data Table on Comparison by Distribution Channel
7.3 Hospital pharmacy - Market size and forecast 2022-2027
Exhibit 55: Chart on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibit 56: Data Table on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Chart on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
Exhibit 58: Data Table on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
7.4 Retail pharmacy - Market size and forecast 2022-2027
Exhibit 59: Chart on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibit 60: Data Table on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibit 61: Chart on Retail pharmacy - Year-over-year growth 2022-2027 (%)
Exhibit 62: Data Table on Retail pharmacy - Year-over-year growth 2022-2027 (%)
7.5 E-pharmacy - Market size and forecast 2022-2027
Exhibit 63: Chart on E-pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibit 64: Data Table on E-pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibit 65: Chart on E-pharmacy - Year-over-year growth 2022-2027 (%)
Exhibit 66: Data Table on E-pharmacy - Year-over-year growth 2022-2027 (%)
7.6 Market opportunity by Distribution Channel
Exhibit 67: Market opportunity by Distribution Channel ($ million)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 69: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 70: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 71: Chart on Geographic comparison
Exhibit 72: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 73: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 74: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 75: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 76: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 77: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 78: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 79: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 80: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 81: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 82: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 83: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 84: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 85: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 86: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 87: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 88: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 89: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 90: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 91: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 92: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Germany - Market size and forecast 2022-2027
Exhibit 93: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 94: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 95: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 96: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.9 China - Market size and forecast 2022-2027
Exhibit 97: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 98: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 99: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 100: Data Table on China - Year-over-year growth 2022-2027 (%)
9.10 Canada - Market size and forecast 2022-2027
Exhibit 101: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 102: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 103: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 104: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.11 UK - Market size and forecast 2022-2027
Exhibit 105: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 106: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 107: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 108: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 109: Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 110: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 111: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 112: Overview on factors of disruption
11.4 Industry risks
Exhibit 113: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 114: Vendors covered
12.2 Market positioning of vendors
Exhibit 115: Matrix on vendor position and classification
12.3 Abbott Laboratories
Exhibit 116: Abbott Laboratories - Overview
Exhibit 117: Abbott Laboratories - Business segments
Exhibit 118: Abbott Laboratories - Key news
Exhibit 119: Abbott Laboratories - Key offerings
Exhibit 120: Abbott Laboratories - Segment focus
12.4 AbbVie Inc.
Exhibit 121: AbbVie Inc. - Overview
Exhibit 122: AbbVie Inc. - Product / Service
Exhibit 123: AbbVie Inc. - Key offerings
12.5 Amgen Inc.
Exhibit 124: Amgen Inc. - Overview
Exhibit 125: Amgen Inc. - Product / Service
Exhibit 126: Amgen Inc. - Key offerings
12.6 Bristol Myers Squibb Co.
Exhibit 127: Bristol Myers Squibb Co. - Overview
Exhibit 128: Bristol Myers Squibb Co. - Product / Service
Exhibit 129: Bristol Myers Squibb Co. - Key offerings
12.7 Daiichi Sankyo Co. Ltd.
Exhibit 130: Daiichi Sankyo Co. Ltd. - Overview
Exhibit 131: Daiichi Sankyo Co. Ltd. - Business segments
Exhibit 132: Daiichi Sankyo Co. Ltd. - Key news
Exhibit 133: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibit 134: Daiichi Sankyo Co. Ltd. - Segment focus
12.8 F. Hoffmann La Roche Ltd.
Exhibit 135: F. Hoffmann La Roche Ltd. - Overview
Exhibit 136: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 137: F. Hoffmann La Roche Ltd. - Key news
Exhibit 138: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 139: F. Hoffmann La Roche Ltd. - Segment focus
12.9 GlaxoSmithKline Plc
Exhibit 140: GlaxoSmithKline Plc - Overview
Exhibit 141: GlaxoSmithKline Plc - Business segments
Exhibit 142: GlaxoSmithKline Plc - Key offerings
Exhibit 143: GlaxoSmithKline Plc - Segment focus
12.10 Johnson and Johnson
Exhibit 144: Johnson and Johnson - Overview
Exhibit 145: Johnson and Johnson - Business segments
Exhibit 146: Johnson and Johnson - Key news
Exhibit 147: Johnson and Johnson - Key offerings
Exhibit 148: Johnson and Johnson - Segment focus
12.11 Merck and Co. Inc.
Exhibit 149: Merck and Co. Inc. - Overview
Exhibit 150: Merck and Co. Inc. - Business segments
Exhibit 151: Merck and Co. Inc. - Key news
Exhibit 152: Merck and Co. Inc. - Key offerings
Exhibit 153: Merck and Co. Inc. - Segment focus
12.12 Novartis AG
Exhibit 154: Novartis AG - Overview
Exhibit 155: Novartis AG - Business segments
Exhibit 156: Novartis AG - Key offerings
Exhibit 157: Novartis AG - Segment focus
12.13 Pfizer Inc.
Exhibit 158: Pfizer Inc. - Overview
Exhibit 159: Pfizer Inc. - Product / Service
Exhibit 160: Pfizer Inc. - Key news
Exhibit 161: Pfizer Inc. - Key offerings
12.14 PharmaMar SA
Exhibit 162: PharmaMar SA - Overview
Exhibit 163: PharmaMar SA - Business segments
Exhibit 164: PharmaMar SA - Key news
Exhibit 165: PharmaMar SA - Key offerings
Exhibit 166: PharmaMar SA - Segment focus
12.15 Sanofi SA
Exhibit 167: Sanofi SA - Overview
Exhibit 168: Sanofi SA - Business segments
Exhibit 169: Sanofi SA - Key news
Exhibit 170: Sanofi SA - Key offerings
Exhibit 171: Sanofi SA - Segment focus
12.16 Takeda Pharmaceutical Co. Ltd.
Exhibit 172: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibit 173: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibit 174: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibit 175: Takeda Pharmaceutical Co. Ltd. - Key offerings
12.17 Teva Pharmaceutical Industries Ltd.
Exhibit 176: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 177: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 178: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 179: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 180: Teva Pharmaceutical Industries Ltd. - Segment focus

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 181: Inclusions checklist
Exhibit 182: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 183: Currency conversion rates for US$
13.4 Research methodology
Exhibit 184: Research methodology
Exhibit 185: Validation techniques employed for market sizing
Exhibit 186: Information sources
13.5 List of abbreviations
Exhibit 187: List of abbreviations

Product Code: IRTNTR74700

Exhibits:

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Therapy
Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on Global multiple myeloma drugs market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Therapy Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Therapy - Market share 2022-2027 (%)
Exhibits31: Data Table on Therapy - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Therapy
Exhibits33: Data Table on Comparison by Therapy
Exhibits34: Chart on Targeted therapy - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Targeted therapy - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Targeted therapy - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Targeted therapy - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Biologic therapy - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Biologic therapy - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Biologic therapy - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Biologic therapy - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Chemotherapy - Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Chemotherapy - Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Chemotherapy - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Chemotherapy - Year-over-year growth 2022-2027 (%)
Exhibits46: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits47: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits48: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits49: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits50: Market opportunity by Therapy ($ million)
Exhibits51: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibits52: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibits53: Chart on Comparison by Distribution Channel
Exhibits54: Data Table on Comparison by Distribution Channel
Exhibits55: Chart on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits56: Data Table on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits57: Chart on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits58: Data Table on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits59: Chart on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits60: Data Table on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits61: Chart on Retail pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits62: Data Table on Retail pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits63: Chart on E-pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits64: Data Table on E-pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits65: Chart on E-pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits66: Data Table on E-pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits67: Market opportunity by Distribution Channel ($ million)
Exhibits68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits69: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits70: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits71: Chart on Geographic comparison
Exhibits72: Data Table on Geographic comparison
Exhibits73: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits74: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits75: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits98: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits99: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits101: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits102: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits103: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits104: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits105: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits106: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits107: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits108: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits109: Market opportunity By Geographical Landscape ($ million)
Exhibits110: Impact of drivers and challenges in 2022 and 2027
Exhibits111: Overview on Criticality of inputs and Factors of differentiation
Exhibits112: Overview on factors of disruption
Exhibits113: Impact of key risks on business
Exhibits114: Vendors covered
Exhibits115: Matrix on vendor position and classification
Exhibits116: Abbott Laboratories - Overview
Exhibits117: Abbott Laboratories - Business segments
Exhibits118: Abbott Laboratories - Key news
Exhibits119: Abbott Laboratories - Key offerings
Exhibits120: Abbott Laboratories - Segment focus
Exhibits121: AbbVie Inc. - Overview
Exhibits122: AbbVie Inc. - Product / Service
Exhibits123: AbbVie Inc. - Key offerings
Exhibits124: Amgen Inc. - Overview
Exhibits125: Amgen Inc. - Product / Service
Exhibits126: Amgen Inc. - Key offerings
Exhibits127: Bristol Myers Squibb Co. - Overview
Exhibits128: Bristol Myers Squibb Co. - Product / Service
Exhibits129: Bristol Myers Squibb Co. - Key offerings
Exhibits130: Daiichi Sankyo Co. Ltd. - Overview
Exhibits131: Daiichi Sankyo Co. Ltd. - Business segments
Exhibits132: Daiichi Sankyo Co. Ltd. - Key news
Exhibits133: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibits134: Daiichi Sankyo Co. Ltd. - Segment focus
Exhibits135: F. Hoffmann La Roche Ltd. - Overview
Exhibits136: F. Hoffmann La Roche Ltd. - Business segments
Exhibits137: F. Hoffmann La Roche Ltd. - Key news
Exhibits138: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits139: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits140: GlaxoSmithKline Plc - Overview
Exhibits141: GlaxoSmithKline Plc - Business segments
Exhibits142: GlaxoSmithKline Plc - Key offerings
Exhibits143: GlaxoSmithKline Plc - Segment focus
Exhibits144: Johnson and Johnson - Overview
Exhibits145: Johnson and Johnson - Business segments
Exhibits146: Johnson and Johnson - Key news
Exhibits147: Johnson and Johnson - Key offerings
Exhibits148: Johnson and Johnson - Segment focus
Exhibits149: Merck and Co. Inc. - Overview
Exhibits150: Merck and Co. Inc. - Business segments
Exhibits151: Merck and Co. Inc. - Key news
Exhibits152: Merck and Co. Inc. - Key offerings
Exhibits153: Merck and Co. Inc. - Segment focus
Exhibits154: Novartis AG - Overview
Exhibits155: Novartis AG - Business segments
Exhibits156: Novartis AG - Key offerings
Exhibits157: Novartis AG - Segment focus
Exhibits158: Pfizer Inc. - Overview
Exhibits159: Pfizer Inc. - Product / Service
Exhibits160: Pfizer Inc. - Key news
Exhibits161: Pfizer Inc. - Key offerings
Exhibits162: PharmaMar SA - Overview
Exhibits163: PharmaMar SA - Business segments
Exhibits164: PharmaMar SA - Key news
Exhibits165: PharmaMar SA - Key offerings
Exhibits166: PharmaMar SA - Segment focus
Exhibits167: Sanofi SA - Overview
Exhibits168: Sanofi SA - Business segments
Exhibits169: Sanofi SA - Key news
Exhibits170: Sanofi SA - Key offerings
Exhibits171: Sanofi SA - Segment focus
Exhibits172: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits173: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits174: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits175: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits176: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits177: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits178: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits179: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits180: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits181: Inclusions checklist
Exhibits182: Exclusions checklist
Exhibits183: Currency conversion rates for US$
Exhibits184: Research methodology
Exhibits185: Validation techniques employed for market sizing
Exhibits186: Information sources
Exhibits187: List of abbreviations